InvestorsHub Logo
icon url

BiotechValues

02/07/14 1:08 PM

#1640 RE: sunscreen99 #1639

The fundamentals are that the company is trading just above book value, generated near record revenue last year, and is restructuring to focus on 3D printing/AM, and not low margin CNC subsidiary.

The 10 million euro loan/raise will allow them to do that.

You make money in the market by being out ahead of it, not with or behind it.

Some of my best investments have been in situations exactly like Alphaform and doing exactly what the market doesn't see 3-6 months down the road. (See SGLB, AMAVF, GOE).

The fact that there is already an ADR set to go for Alphaform is proof there is US investor demand- and when more of them see this company's forward potential - estimated to be .26/share by close Brothers Group in 2014, they will be the market.

.26/share is about what SSYS is estimating (GAAP) for 2014 incidentally. Can AFRMF get there? Probably not in my opinion. But (in my opinion) will thye be profitable this year with Germany leading the Eurozone recovery? Yes. Yes. Yes, they will.

I am not a "follower" of what the market does- not in 3D printing stocks.